GW 695634

Drug Profile

GW 695634

Alternative Names: 695634; GW 695634G; GW-5634; GW-695634; GW678248

Latest Information Update: 22 Jun 2006

Price : $50

At a glance

  • Originator GlaxoSmithKline
  • Class Antiretrovirals
  • Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued HIV-1 infections

Most Recent Events

  • 16 Dec 2016 Biomarkers information updated
  • 31 Dec 2005 Discontinued - Phase-II for HIV-1 infections in USA (PO)
  • 22 Aug 2005 Data presented at the 3rd Conference on HIV Pathogenesis and Treatment have been added to the Viral infections therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top